Document is current
Any future updates will be listed below
-
Authors
Ester-Nacke, Theresa https://orcid.org/0000-0003-1342-6302
Berti, Katharina
Veit, Ralf https://orcid.org/0000-0001-9860-642X
Dannecker, Corinna
Salvador, Ricardo https://orcid.org/0000-0001-5985-1473
Ruffini, Giulio https://orcid.org/0000-0003-3084-0177
Heni, Martin https://orcid.org/0000-0002-8462-3832
Birkenfeld, Andreas L. https://orcid.org/0000-0003-1407-9023
Plewnia, Christian https://orcid.org/0000-0003-3852-9906
Preissl, Hubert https://orcid.org/0000-0002-8859-4661
Kullmann, Stephanie https://orcid.org/0000-0001-9951-923X
-
Funding
Funding for this research was provided by:
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
DZD e.V. (01GI0925)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- License Information
-
More Information
Article History
Received: 31 October 2023
Accepted: 10 May 2024
First Online: 18 May 2024
Competing interests
: GR is a co-founder and shareholder and works for Neuroelectrics, a company developing medical devices for NIBS. RS works for Neuroelectrics. Outside of the current work, MH reports research grants from Boehringer Ingelheim and Sanofi to the University Hospital of Tübingen, participation in advisory board for Boehringer Ingelheim, Sanofi and Amryt, and lecture fees from Amryt, Bayer, Sanofi, Eli Lilly, Novartis, Novo Nordisk and Boehringer Ingelheim. TEN, KB, RV, CD, ALB, CP, HP and SK report no conflict of interest.
